Antimicrobial Resistance — MCQs

Antimicrobial Resistance Indian Medical PG Practice Questions and MCQs

Question 21: Which gene is responsible for semisynthetic penicillin resistance in Methicillin-resistant Staphylococcus aureus (MRSA)?

A. MecA (Correct Answer)
B. MecB
C. MecD
D. MecC

Explanation: **Explanation:** **1. Why Option A (MecA) is Correct:** The hallmark of Methicillin-resistant *Staphylococcus aureus* (MRSA) is the acquisition of the **mecA gene**. This gene is located on a mobile genetic element called the **Staphylococcal Cassette Chromosome mec (SCCmec)**. The mecA gene encodes an altered penicillin-binding protein known as **PBP2a** (or PBP2’). Unlike normal PBPs, PBP2a has a very low affinity for β-lactam antibiotics, including semisynthetic penicillins (methicillin, oxacillin, nafcillin) and most cephalosporins. This allows the bacteria to continue cell wall synthesis even in the presence of these drugs. **2. Why Other Options are Incorrect:** * **MecB & MecD:** These are rare variants primarily identified in other staphylococcal species (like *S. sciuri*) or macrococci. They are not the primary drivers of MRSA in clinical human isolates. * **MecC:** This is a divergent homolog of mecA (sharing ~70% identity). While it also causes MRSA, it is much less common than mecA and is typically associated with livestock-associated MRSA in Europe. It is often missed by traditional PCR primers designed for mecA. **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Vancomycin is the gold standard for MRSA. For VRSA/VRE, consider Linezolid or Daptomycin. * **Cephalosporin Exception:** **Ceftaroline** (5th generation) is the only cephalosporin with activity against MRSA because it can bind to PBP2a. * **Screening:** Cefoxitin disk diffusion is the preferred method for detecting MRSA in the lab, as it is a better inducer of the mecA gene than oxacillin. * **Gold Standard Test:** Detection of the **mecA gene by PCR** is the definitive diagnostic method.

Question 22: Which of the following is NOT a mechanism of resistance to MRSA?

A. Resistance is chromosomally mediated.
B. Produced mainly by alteration in penicillin-binding proteins (PBPs).
C. MRSA resistance is absolutely beta-lactamase independent. (Correct Answer)
D. Intrinsic resistance is absent.

Explanation: ### Explanation **1. Why Option C is the Correct Answer (The "NOT" Mechanism):** The statement that MRSA resistance is "absolutely beta-lactamase independent" is incorrect. While the hallmark of MRSA is the production of an altered **PBP-2a** (which has low affinity for beta-lactams), most MRSA strains **also produce beta-lactamase enzymes**. Therefore, their resistance profile is a combination of both mechanisms. While PBP alteration is the primary reason they resist penicillinase-resistant penicillins (like Oxacillin/Methicillin), they still utilize beta-lactamases to hydrolyze standard penicillins. **2. Analysis of Incorrect Options:** * **Option A (Chromosomally mediated):** This is a true statement. The resistance is mediated by the **mecA gene**, which is located on the bacterial chromosome within a mobile genetic element called the **Staphylococcal Cassette Chromosome (SCCmec)**. * **Option B (Alteration in PBPs):** This is the definitive mechanism of MRSA. The *mecA* gene encodes **PBP-2a**, a transpeptidase that maintains cell wall synthesis even in the presence of methicillin, which normally inhibits native PBPs. * **Option D (Intrinsic resistance is absent):** This is true. MRSA resistance is **acquired** (via the SCCmec element) rather than intrinsic. *Staphylococcus aureus* is naturally susceptible to penicillins; it only becomes MRSA after acquiring the *mecA* gene. **3. Clinical Pearls for NEET-PG:** * **Drug of Choice:** Vancomycin is the traditional gold standard for MRSA. * **Screening:** Cefoxitin disk diffusion is preferred over Oxacillin for detecting MRSA because it is a better inducer of the *mecA* gene. * **Exceptions:** The only beta-lactams effective against MRSA are **5th generation cephalosporins** (e.g., Ceftaroline, Ceftobiprole), which have a high affinity for PBP-2a. * **Borderline Oxacillin Resistant S. aureus (BORSA):** These strains lack the *mecA* gene but show resistance due to massive overproduction of beta-lactamases.

Question 23: Which of the following drug classes does not exhibit cross-reactivity with penicillin allergy?

A. Aminoglycosides
B. Oxazolidinones
C. Lincosamides
D. Carbapenems (Correct Answer)

Explanation: **Explanation:** The core concept behind penicillin cross-reactivity is the presence of the **$\beta$-lactam ring**. Penicillins, Cephalosporins, Carbapenems, and Monobactams all belong to the $\beta$-lactam family. Cross-reactivity occurs because the immune system recognizes similar structural epitopes across these classes. **Why Carbapenems is the Correct Answer (Contextual to the Question):** Among the options provided, **Carbapenems** are the only class that belongs to the $\beta$-lactam family. While the question asks which class *does not* exhibit cross-reactivity, there appears to be a conceptual mismatch in the provided key. **In clinical reality, Aminoglycosides, Oxazolidinones, and Lincosamides have zero cross-reactivity with penicillin** because they lack the $\beta$-lactam ring. However, if the question intends to test "allowable" alternatives or "low-risk" $\beta$-lactams: * **Carbapenems** have a structural similarity but show a low cross-reactivity rate (<1%) with penicillins. * **Monobactams (Aztreonam)** are the only $\beta$-lactams with **zero** cross-reactivity with penicillin (except for Ceftazidime). **Analysis of Incorrect Options:** * **Aminoglycosides (e.g., Gentamicin):** Protein synthesis inhibitors (30S). No structural similarity to penicillins; safe to use. * **Oxazolidinones (e.g., Linezolid):** Protein synthesis inhibitors (50S). No structural similarity; safe to use. * **Lincosamides (e.g., Clindamycin):** Protein synthesis inhibitors (50S). No structural similarity; often used as an alternative for dental prophylaxis in penicillin-allergic patients. **NEET-PG High-Yield Pearls:** 1. **Aztreonam** is the "classic" answer for a $\beta$-lactam safe in penicillin-allergic patients (except if allergic to Ceftazidime). 2. **Cross-reactivity rates:** 1st Gen Cephalosporins (~3-5%), Carbapenems (<1%). 3. **Mechanism of Penicillin Allergy:** Type I Hypersensitivity (IgE mediated) is the most concerning. 4. **Drug of choice** for MRSA in a penicillin-allergic patient is often **Vancomycin** or **Linezolid**.

Question 24: Which of the following drugs is used against the bacterium Pseudomonas aeruginosa?

A. Piperacillin-Tazobactam (Correct Answer)
B. Cefotaxime
C. Streptomycin
D. Cephalexin

Explanation: **Explanation:** *Pseudomonas aeruginosa* is a notorious Gram-negative opportunistic pathogen characterized by its high level of intrinsic and acquired resistance. Managing Pseudomonas requires specific "anti-pseudomonal" agents. **1. Why Piperacillin-Tazobactam is correct:** Piperacillin is an **extended-spectrum penicillin (Ureidopenicillin)** specifically designed to penetrate the outer membrane of *Pseudomonas*. It inhibits cell wall synthesis by binding to penicillin-binding proteins (PBPs). Tazobactam is a beta-lactamase inhibitor that protects Piperacillin from degradation by certain bacterial enzymes. This combination is a first-line "workhorse" antibiotic for nosocomial infections like ventilator-associated pneumonia and neutropenic sepsis where *Pseudomonas* is suspected. **2. Why the other options are incorrect:** * **Cefotaxime:** This is a 3rd-generation cephalosporin. While it has excellent Gram-negative coverage, it is **not** effective against *Pseudomonas*. Only specific 3rd-generation (Ceftazidime) and 4th-generation (Cefepime) cephalosporins have anti-pseudomonal activity. * **Streptomycin:** An aminoglycoside primarily used for Tuberculosis and Plague. While other aminoglycosides (Amikacin, Gentamicin) are used against *Pseudomonas*, Streptomycin lacks sufficient activity against it. * **Cephalexin:** A 1st-generation cephalosporin used mainly for Gram-positive skin infections and uncomplicated UTIs. It has no activity against *Pseudomonas*. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Anti-pseudomonal drugs:** **"CAMP FIRE"** * **C:** Carbapenems (Imipenem, Meropenem—but NOT Ertapenem!) * **A:** Aminoglycosides (Amikacin, Gentamicin, Tobramycin) * **M:** Monobactams (Aztreonam) * **P:** Polymyxins (Colistin, Polymyxin B) * **F:** Fluoroquinolones (Ciprofloxacin, Levofloxacin) * **I:** Inhibitors of Beta-lactamase (Piperacillin-Tazobactam, Ticarcillin-Clavulanate) * **RE:** RE-generation Cephalosporins (Ceftazidime, Cefepime, Cefoperazone) * **Key Fact:** *Pseudomonas* is an obligate aerobe, oxidase-positive, and produces a characteristic blue-green pigment (Pyocyanin).

Question 25: Extended activity of beta-lactamases inactivates which of the following?

A. Cephalosporins - third generation (Correct Answer)
B. Macrolides
C. Quinolones
D. Quinolones

Explanation: **Explanation:** The question refers to **Extended-Spectrum Beta-Lactamases (ESBLs)**. These are enzymes produced by certain bacteria (most commonly *E. coli* and *Klebsiella pneumoniae*) that mediate resistance to a wide range of beta-lactam antibiotics. **1. Why Option A is Correct:** ESBLs are a specific class of beta-lactamases that have evolved to hydrolyze and inactivate **extended-spectrum cephalosporins** (3rd generation like Ceftriaxone, Cefotaxime, and Ceftazidime) and monobactams (Aztreonam). They do not, however, affect Carbapenems or Cephamycins (like Cefoxitin). **2. Why Other Options are Incorrect:** * **Options B, C, and D (Macrolides and Quinolones):** These are non-beta-lactam antibiotics. * **Macrolides** (e.g., Azithromycin) inhibit protein synthesis by binding to the 50S ribosomal subunit. * **Quinolones** (e.g., Ciprofloxacin) inhibit DNA synthesis by targeting DNA gyrase and Topoisomerase IV. * Since beta-lactamases specifically target the **beta-lactam ring** structure, they have no enzymatic activity against these classes of drugs. Resistance to these drugs occurs via different mechanisms like efflux pumps or target site mutations. **High-Yield Clinical Pearls for NEET-PG:** * **Treatment of Choice:** Carbapenems (e.g., Meropenem) are the drugs of choice for serious infections caused by ESBL-producing organisms. * **Inhibitor Sensitivity:** ESBLs are typically inhibited by beta-lactamase inhibitors like **Clavulanic acid**, Sulbactam, and Tazobactam. * **Detection:** In the lab, ESBL production is confirmed by the "Double Disk Approximation Test" or "Phenotypic Synergy Test." * **Gene Association:** Most ESBLs are plasmid-mediated, commonly involving the **TEM, SHV, and CTX-M** gene families.

Question 26: Ureaplasma is naturally resistant to which of the following antibiotics?

A. Erythromycin
B. Tetracycline
C. Chloramphenicol
D. Cephalosporins (Correct Answer)

Explanation: ### Explanation **Correct Option: D. Cephalosporins** The fundamental concept here is the **mechanism of action** of beta-lactam antibiotics and the **structural biology** of *Ureaplasma*. *Ureaplasma* species (along with *Mycoplasma*) belong to the class *Mollicutes*. These organisms are unique among bacteria because they **lack a peptidoglycan cell wall**; they are bounded only by a triple-layered lipid membrane. Cephalosporins, like penicillins and other beta-lactams, exert their antibacterial effect by inhibiting cell wall synthesis (specifically by binding to Penicillin-Binding Proteins and preventing peptidoglycan cross-linking). Since *Ureaplasma* does not possess a cell wall, it is **intrinsically (naturally) resistant** to all beta-lactam antibiotics, including Cephalosporins. --- ### Analysis of Incorrect Options: * **A. Erythromycin:** This is a macrolide that inhibits protein synthesis by binding to the 50S ribosomal subunit. While some strains of *Ureaplasma* may show acquired resistance, they are generally susceptible to macrolides. * **B. Tetracycline:** These drugs inhibit the 30S ribosomal subunit. Tetracyclines (like Doxycycline) have historically been the first-line treatment for *Ureaplasma* infections. * **C. Chloramphenicol:** This antibiotic also targets the 50S ribosomal subunit. *Ureaplasma* is susceptible to chloramphenicol *in vitro*, though it is rarely used clinically due to toxicity. --- ### High-Yield Clinical Pearls for NEET-PG: * **Cell Wall Deficient:** *Mycoplasma* and *Ureaplasma* are the smallest free-living organisms. Because they lack a cell wall, they are **pleomorphic** and do not Gram stain. * **Urease Activity:** *Ureaplasma urealyticum* is distinguished from *Mycoplasma* by its ability to produce **urease**, which hydrolyzes urea to ammonia (often associated with staghorn calculi/struvite stones). * **Drug of Choice:** Azithromycin or Doxycycline are typically used for infections caused by these organisms. * **Sterols:** They are the only bacteria that require **cholesterol/sterols** for growth, which they incorporate into their cell membranes.

Question 27: Pneumococcal resistance to penicillin G is mainly acquired by what mechanism?

A. Conjugation
B. Transduction
C. Transformation (Correct Answer)
D. All of the above

Explanation: **Explanation:** **1. Why Transformation is Correct:** *Streptococcus pneumoniae* (Pneumococcus) is a naturally competent bacterium, meaning it can actively take up exogenous DNA from its environment. Resistance to Penicillin G in Pneumococci is mediated by **alterations in Penicillin-Binding Proteins (PBPs)**, specifically PBP 2b, 2x, and 1a. Instead of acquiring a plasmid, the bacteria undergo **Transformation** by taking up DNA fragments from related viridans group streptococci. This foreign DNA is integrated into the pneumococcal genome via homologous recombination, creating "mosaic genes" that encode PBPs with a low affinity for beta-lactam antibiotics. **2. Why Other Options are Incorrect:** * **Conjugation (A):** This involves direct cell-to-cell contact via a sex pilus to transfer plasmids. While common in Gram-negative rods (e.g., *E. coli*), it is not the primary mechanism for pneumococcal penicillin resistance. * **Transduction (B):** This is the transfer of genetic material via a bacteriophage (virus). While it occurs in *Staphylococcus aureus* (e.g., for penicillinase production), it is not the mechanism for PBP modification in Pneumococci. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism Summary:** Pneumococcal resistance = **Mosaic Genes** via **Transformation** → **Altered PBPs**. * **Not Beta-lactamase:** Unlike Staphylococci, Pneumococcal resistance is **NOT** due to beta-lactamase production. Therefore, adding a beta-lactamase inhibitor (like Clavulanic acid) does not overcome this resistance. * **Drug of Choice:** For highly resistant strains (MDRSP), **Vancomycin** or **Linezolid** are often utilized. * **Other Transformation Examples:** *Neisseria gonorrhoeae* and *Haemophilus influenzae* also utilize transformation for genetic diversity and resistance.

Question 28: What is the most commonly used method for testing antibiotic susceptibility of bacteria?

A. Kirby-Bauer disc diffusion method (Correct Answer)
B. Epsilometer test (E test)
C. Broth dilution method
D. Stoke disc diffusion method

Explanation: ### Explanation **Correct Answer: A. Kirby-Bauer disc diffusion method** The **Kirby-Bauer disc diffusion method** is the most widely used technique in clinical microbiology laboratories for routine antibiotic susceptibility testing (AST). Its popularity stems from its simplicity, cost-effectiveness, and the ability to test multiple antibiotics simultaneously against a single isolate. **Why it is the correct choice:** * **Mechanism:** Antibiotic-impregnated paper discs are placed on a Mueller-Hinton Agar (MHA) plate inoculated with a standardized bacterial suspension (0.5 McFarland standard). The drug diffuses into the agar, and the resulting **Zone of Inhibition** is measured. * **Standardization:** It is standardized by the Clinical and Laboratory Standards Institute (CLSI), allowing for reproducible results categorized as Sensitive, Intermediate, or Resistant. **Analysis of Incorrect Options:** * **B. Epsilometer test (E test):** While highly accurate, it is expensive. It is a hybrid method that uses a plastic strip to determine the **Minimum Inhibitory Concentration (MIC)**. It is reserved for specific clinical scenarios rather than routine use. * **C. Broth dilution method:** This is the **"Gold Standard"** for determining MIC. However, it is labor-intensive and technically demanding, making it less common for routine daily testing compared to Kirby-Bauer. * **D. Stoke disc diffusion method:** This is a variation where a control strain and the test strain are inoculated on the same plate. It is rarely used today as standardized Kirby-Bauer protocols have superseded it. **High-Yield Clinical Pearls for NEET-PG:** * **Culture Media:** **Mueller-Hinton Agar (MHA)** is the standard medium for AST because it shows low sulfonamide, trimethoprim, and tetracycline inhibitors. * **Standard Inoculum:** 0.5 McFarland turbidity (approx. $1.5 \times 10^8$ CFU/ml). * **Agar Depth:** Must be exactly **4 mm**; if too thin, zones will be falsely large; if too thick, zones will be falsely small. * **pH:** Must be maintained between **7.2 and 7.4**.

Question 29: Stepwise mutation for drug resistance is seen with which of the following drugs?

A. Penicillin (Correct Answer)
B. Streptomycin
C. Garamycin
D. Kanamycin

Explanation: **Explanation:** Drug resistance in bacteria can develop through different patterns of mutation. The two primary patterns are the **Stepwise (Small-step) mutation** and the **Large-step mutation**. **Why Penicillin is Correct:** Penicillin follows the **Stepwise mutation pattern** (also known as the "Penicillin-type" resistance). In this process, resistance develops gradually through a series of multiple, sequential mutations. Each individual mutation only slightly increases the Minimum Inhibitory Concentration (MIC). Therefore, clinical resistance emerges slowly over a long period of exposure. This is why increasing the dosage of penicillin can sometimes overcome low-level resistance initially. **Why the Other Options are Incorrect:** * **B. Streptomycin:** This drug follows the **Large-step mutation pattern** (also known as the "Streptomycin-type" resistance). A single-step mutation in the chromosomal gene (rpsL) can result in an immediate, high level of resistance, making the drug completely ineffective rapidly. * **C. Garamycin (Gentamicin) & D. Kanamycin:** These are aminoglycosides. While they can develop chromosomal resistance, their most common mode of resistance in a clinical setting is through **extrachromosomal inheritance** (R-plasmids) via enzymes that modify the drug (e.g., acetyltransferases), rather than the classic stepwise chromosomal mutation seen with Penicillin. **High-Yield Clinical Pearls for NEET-PG:** * **Stepwise Mutation:** Seen with Penicillin, Erythromycin, and Chloramphenicol. * **Large-step Mutation:** Seen with Streptomycin, Rifampicin, and Nalidixic acid. * **Mnemonic:** "Steps are for Pens" (Stepwise = Penicillin). * **Clinical Significance:** To prevent the emergence of resistance in drugs that follow the large-step pattern (like Rifampicin in TB), they are always used in **combination therapy**.

Question 30: Colistin is not active against which of the following bacteria?

A. Pseudomonas aeruginosa
B. Serratia (Correct Answer)
C. Klebsiella pneumoniae
D. Burkholderia

Explanation: **Explanation:** The correct answer is **Serratia**. This question tests the knowledge of **intrinsic resistance** to Polymyxins (Colistin and Polymyxin B). **1. Why Serratia is correct:** Colistin works by acting as a cationic detergent that disrupts the bacterial outer membrane by binding to lipopolysaccharides (LPS). Certain Gram-negative bacteria possess intrinsic (natural) resistance to Colistin, usually due to modifications in their LPS structure that prevent the drug from binding. **Serratia marcescens** is a classic example of a Gram-negative organism that is innately resistant to Colistin. **2. Why other options are incorrect:** * **Pseudomonas aeruginosa (A) and Klebsiella pneumoniae (C):** These are typical targets for Colistin. Colistin is often used as a "last-resort" drug for Multidrug-Resistant (MDR) strains of these organisms, including Carbapenem-Resistant Enterobacteriaceae (CRE). * **Burkholderia (D):** While *Burkholderia cepacia* is also intrinsically resistant to Colistin, the question asks which of the provided options is correct. In many standardized exams, if both are present, *Serratia* or *Proteus* are the most frequently tested "high-yield" examples of intrinsic resistance. (Note: *Burkholderia* is indeed resistant, but *Serratia* is the primary intended answer in this specific MCQ context). **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Colistin Resistance:** " **B**e **P**repared **S**oon **M**aybe **H**elp" → ***B**urkholderia, **P**roteus, **P**rovidencia, **S**erratia, **M**organella, **H**afnia*. * **Mechanism of Action:** Disrupts the cell membrane (detergent-like action). * **Toxicity:** Nephrotoxicity and Neurotoxicity are the major side effects. * **Acquired Resistance:** Watch for the **mcr-1 gene**, which mediates plasmid-borne resistance to Colistin, a major global health concern.

Practice by Chapter

Mechanisms of Antimicrobial Resistance

Practice Questions

Beta-lactamase Producing Organisms

Practice Questions

Methicillin-Resistant Staphylococcus aureus

Practice Questions

Vancomycin-Resistant Enterococci

Practice Questions

Carbapenem-Resistant Enterobacteriaceae

Practice Questions

Multi-drug Resistant Tuberculosis

Practice Questions

Antimicrobial Stewardship

Practice Questions

Detection of Antimicrobial Resistance

Practice Questions

Global Surveillance of Resistance

Practice Questions

New Antimicrobial Development

Practice Questions

Alternative Approaches to Antimicrobial Therapy

Practice Questions

One Health Approach to Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free